TRV734

DRUG2 trials

Sponsors

Trevena Inc., National Institute on Drug Abuse (NIDA)

Conditions

HealthyOpioid-Use Disorder

Phase 1

A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males

CompletedNCT02411500

Trevena Inc.Healthy

Start: 2015-02-28End: 2015-03-31Updated: 2015-11-18

Phase 2

Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD

TerminatedNCT04316559

National Institute on Drug Abuse (NIDA)Opioid-Use Disorder

Start: 2021-12-27End: 2025-02-14Updated: 2026-06-02